A client who is obtunded arrives in the emergency department with a suspected drug overdose. The client becomes responsive after the administration of IV naloxone, but within a short period, the client's level of consciousness decreases again and the respiratory rate decreases to 6 breaths/minute. Which action should the nurse take first?
Administer an additional dose of naloxone.
Initiate a second intravenous access site.
Prepare to initiate cardiopulmonary resuscitation (CPR).
Determine if results of the drug toxicity screen are available.
The Correct Answer is A
A. Administer an additional dose of naloxone: Naloxone has a shorter half-life than many opioids, leading to the recurrence of respiratory depression once its effects wear off. When signs of opioid toxicity return, the immediate priority is to administer another dose of naloxone to reverse life-threatening respiratory depression and restore adequate ventilation.
B. Initiate a second intravenous access site: While maintaining IV access is important in emergency care, establishing a second IV line is not the most urgent priority when the client’s breathing is dangerously slow. Immediate reversal of respiratory depression takes precedence.
C. Prepare to initiate cardiopulmonary resuscitation (CPR): CPR is indicated if the client has no pulse or is not breathing. Since the client is still breathing, although minimally, and has a pulse, the immediate action should be reversing the opioid effects with naloxone, not starting CPR.
D. Determine if results of the drug toxicity screen are available: While knowing the substances involved can guide further treatment, waiting for lab results would delay the critical intervention needed to treat the acute respiratory depression at this moment.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. Serum potassium level of 3.8 mEq/L (3.8 mmol/L): Sodium polystyrene sulfonate is given to treat hyperkalemia by exchanging sodium for potassium in the intestines, promoting potassium elimination. A potassium level within the normal range (3.5 to 5.0 mEq/L) indicates that the medication has effectively lowered dangerously high potassium levels.
B. Serum ammonia level of 30 μg/dL (17.62 μmol/dL): Although a normal ammonia level is important for metabolic balance, sodium polystyrene sulfonate does not target ammonia levels. Changes in ammonia are more relevant to liver function issues, not potassium regulation or AKI management.
C. Hemoglobin level of 13.5 g/dL (135 g/L): Hemoglobin levels are important for evaluating anemia, especially in clients with kidney disease, but sodium polystyrene sulfonate does not affect hemoglobin. This value would not demonstrate the drug’s effectiveness.
D. Serum glucose level of 120 mg/dL (6.7 mmol/L): Elevated glucose could be concerning in clients with diabetes or metabolic disorders but is unrelated to the action of sodium polystyrene sulfonate. Glucose levels are not used to assess the effectiveness of this medication.
Correct Answer is C
Explanation
A. Notify the healthcare provider if anorexia occurs: Anorexia can be a side effect of exenatide, but it is generally mild and often transient. While persistent or severe anorexia should be reported, it is not the most immediate or dangerous concern compared to the risk of hypoglycemia when combining exenatide with a sulfonylurea like glimepiride.
B. Consume additional sources of potassium: Exenatide is not known to cause significant potassium depletion. Hypokalemia is not a common complication with either exenatide or glimepiride therapy, so there is no specific need to focus on increasing potassium intake.
C. Watch for signs of jitteriness or diaphoresis: Combining exenatide with glimepiride significantly increases the risk of hypoglycemia. Symptoms like jitteriness, diaphoresis, shakiness, and confusion are hallmark signs of low blood sugar, making it crucial to educate the client to recognize and manage hypoglycemia promptly.
D. Administer subcutaneously after meals: Exenatide should be administered subcutaneously, but it must be given before meals, typically within 60 minutes prior to eating. Administering it after meals would decrease its effectiveness in controlling postprandial blood glucose spikes.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
